ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1653	National Cancer Institute	Html	en	Cancer Genetics Overview (PDQ®)–Health Professional Version	Expert-reviewed information summary in which the features of hereditary cancer and the structure and content of other PDQ cancer genetics summaries are described. The summary also contains an extensive list of genetics resources available online.	risk assessment 0.737084 germline genetic testing 0.616915 pathogenic germline variants 0.607786 genetics cancer risk 0.586595 germline testing 0.54014 individual PDQ summaries 0.545357 common genetic variants 0.594544 Founder pathogenic variants 0.555775 Cancer Genetics Risk 0.634713 tumor sequencing 0.540563 cancer risk counseling 0.587676 genetic risk 0.584149 health care providers 0.553143 genetic risk assessment 0.574763 family members 0.586643 pathogenic variant 0.712171 cancer predisposition genes 0.581734 cancer risk assessment 0.656292 BRCA1/BRCA2 pathogenic variants 0.580746 rare genetic variants 0.585466 familial cancer risk 0.606217 germline pathogenic variant 0.590911 specific pathogenic variant 0.581389 genetic cancer susceptibility 0.617626 genetic sequence testing 0.55336	breast cancer panel 0.575181 genetic counseling 0.75599 certain pathogenic variants 0.569596 cancer susceptibility genes 0.662603 multigene testing 0.554102 pathogenic variants 0.772898 term pathogenic variant 0.577821 genetic information 0.615701 predisposition genetic testing 0.569525 health care 0.629277 actionable genetic variants 0.56222 cancer susceptibility 0.729483 multigene tests 0.585492 Cancer genetic counseling 0.65952 breast cancer 0.623534 cancer predisposition multigene 0.547293 cancer susceptibility gene 0.552935 well-characterized cancer susceptibility 0.539905 genetic variants 0.628939 prostate cancer 0.563348 genetic testing 0.723596 family history 0.559221 cancer risk 0.746235 cancer 0.908258	CLICK HERE
1834	National Cancer Institute	Html	es	Tratamiento del cáncer de células renales (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de células renales.	vena cava 0.123516 renal carcinoma 0.159056 Compton CC 0.125724 renal-cell carcinoma 0.14068 pazopanib versus sunitinib 0.125846 Sin embargo 0.110933 único tratamiento 0.110403 advanced renal 0.148043 7th ed 0.125599 randomized phase 0.121201 pelvis renal 0.120181 Escudier B 0.130262 dekernion jb 0.116071 patients with advanced 0.115714 nefrectomía citorreductora 0.116589 determinados pacientes 0.124987 Kidney Cancer 0.108755 metastatic renal cell 0.258997 metastatic renal carcinoma 0.150259 meses vs 0.112102 nefrectomía contralateral 0.112298 with metastatic renal 0.190502 Urol Clin North 0.118145 patients with metastatic 0.181521 single-center experience with 0.110273	lymphokine-activated killer cells 0.109085 cell carcinoma with 0.117134 determinados pacientes sobrevivirán 0.111069 metastatic renal 0.292754 Cancer Staging Manual 0.154868 National Cancer Institute 0.108824 advanced or metastatic 0.109154 advanced renal-cell carcinoma 0.125408 vena renal 0.12378 New York 0.121032 renal cell cancer 0.159738 cell carcinoma invading 0.114504 Clin Oncol 0.183599 Clin North Am 0.116365 or metastatic renal 0.109426 with advanced renal 0.117403 Byrd DR 0.123857 metastatic renal-cell carcinoma 0.127732 Tomczak P 0.112446 renal cell carcinoma 0.996231 Renal Pelvis Cancer 0.111495 células renales 0.815564 compared with 0.113419 AJCC Cancer Staging 0.157448	CLICK HERE
1879	National Cancer Institute	Html	es	Tratamiento del cáncer de seno (mama) en el embarazo (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de seno (mama) en el embarazo.	Chua T 0.308433 Rugo HS 0.308741 exposed to chemotherapy 0.30311 Surg Gynecol Obstet 0.330452 outcome after 0.304299 pregnant patient 0.315879 anomalías congénitas 0.308598 Clark RM 0.307911 Theriault R 0.32478 cancer diagnosed during 0.342035 diagnosed during pregnancy 0.34332 Loprinzi CL 0.304379 Sin embargo 0.313532 patient with carcinoma 0.318411 mother during gestation 0.303218 Instituto Nacional 0.305213 Petrek JA 0.304025 Yang WT 0.304051 breast carcinoma during 0.308603 breast carcinoma 0.313568 Gynecol Oncol 0.302701 altas concentraciones 0.304242 cancer diagnosed 0.35036 safety after breast 0.308046 chemotherapy during pregnancy 0.3192	Curr Treat Options 0.317342 administration during pregnancy 0.307821 overall survival after 0.302827 R Coll Radiol 0.316078 Wallack MK 0.309132 Gallenberg MM 0.304139 ultimate challenge 0.308285 Surg Clin North 0.303453 National Cancer Institute 0.306047 during pregnancy 0.532041 Surg Oncol 0.303192 pregnant patient with 0.318156 PDQ Tratamiento 0.303689 after maternal cancer 0.306691 Clin Oncol 0.325015 Radiotherapy during pregnancy 0.307723 breast cancer 0.976679 systematic review 0.303372 Treat Options Oncol 0.318121 Dryden MJ 0.304024 breast cancers from 0.308506 with or without 0.302892 as systemic treatment 0.302539 Gwyn K 0.36898	CLICK HERE
1908	National Cancer Institute	Html	es	Tratamiento de la leucemia mieloide aguda en adultos (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de la leucemia mieloide aguda en adultos.	linfocítica aguda 0.505572 leucemia promielocítica aguda 0.536157 siguientes procedimientos 0.505247 células madre 0.703397 leucemia mielógena aguda 0.512482 posibles factores 0.501447 siguientes aspectos 0.5019 leucemia aguda 0.511873 radiación quizás 0.505162 leucemia linfoblástica aguda 0.535526 LMA quizás 0.505703 hueso compacto 0.505434 neoplasias mieloides 0.501631 rayos x 0.501258 enlace drugs approved 0.505977 Acute Myeloid Leukemia 0.506164 célula madre mieloide 0.516071 cáncer.ampliar aspiración 0.501565 líquido cefalorraquídeo 0.511938	punción espinal.Ampliar 0.501523 National Cancer Institute 0.501258 leucemia granulocítica aguda 0.512402 Instituto Nacional 0.502137 célula madre linfoide 0.510737 PDQ Tratamiento 0.503456 sustancia química benceno 0.502803 leucemia mielógena 0.513696 médula espinal.ampliar quimioterapia 0.50588 leucemia mieloblástica aguda 0.512403 sistema nervioso central 0.50789 Physician Data Query 0.504454 madre mieloides 0.518606 siguientes situaciones 0.504197 células madre mieloides 0.508803 leucemia mieloide aguda 0.995372 célula madre 0.532153 blastocito mieloide 0.505386 siguientes sumarios 0.503116	CLICK HERE
2987	National Cancer Institute	Html	en	Secondhand Smoke	When you smoke, it doesn't just affect you. And it's not just irritating to those around you, it's deadly.	feet 0.409991 dangers 0.420271 Lung cancer 0.428942 good example 0.428021 non-smoker 0.407426 care staff 0.426607 nicotine affect 0.427281 babysitters 0.406286 body 0.411562 smoker 0.414092 children 0.431937 harms 0.407652 sure caretakers 0.428123 secondhand smoke 0.971613 non-smokers 0.43912 heart disease‚ 0.429635 Fact 0.410452 short time 0.429909 somebody 0.406088 health problems 0.428728 smokefree restaurants 0.432863 lung infections 0.428228 smoking indoors 0.445671 main way smoking 0.477206 Breathing problems 0.428866	indoor public places 0.450365 babies 0.424287 smokers 0.419121 air 0.417572 life 0.412446 Breathing secondhand smoke 0.5983 infant death syndrome 0.453829 smoking 0.508887 National Cancer Institute 0.448359 heart attack‚ 0.429618 kids 0.411336 quiz 0.411311 cigarette 0.405834 coughing‚ extra phlegm‚ 0.454984 bronchitis 0.405901 people 0.432125 home 0.416331 nannies 0.405803 severe attacks 0.428972 best thing 0.428251 shortness 0.406847 ear infections 0.428442 low birth weight 0.454001 family 0.425482	CLICK HERE
3514	National Cancer Institute	Html	en	What Are Clinical Trials?	Information about the basics of cancer clinical trials.	new ways 0.630193 cancer cells 0.475957 lab 0.434305 current treatments 0.466814 life 0.434324 successful cancer treatments 0.521796 protocol 0.451986 myth 0.41589 past clinical trials 0.525022 clinical trials 0.959728 animals 0.41616 plan 0.415114 longer lives 0.47341 knowledge 0.414644 final step 0.483148 cancer care 0.469342 new treatment 0.469236 disease 0.417585 charge 0.415053	new treatments 0.461251 researchers 0.43553 NCI-Supported Clinical Trials 0.532591 future patients 0.47375 people 0.521173 long process 0.483044 quality 0.434346 doctor 0.432193 effects 0.4317 cancer clinical trials 0.54508 principal investigator 0.542203 doctors 0.435633 needs treatment 0.4739 stages 0.415306 cancer 0.611137 research studies 0.485202 information 0.432449 time 0.415923	CLICK HERE
15609	National Cancer Institute	Html	es	Tratamiento de los tumores vasculares infantiles (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de los tumores vasculares infantiles.	problemas pasajeros 0.409161 lesiones benignas 0.409862 piel vecina 0.430821 efectos secundarios meses 0.423036 importantes preguntas 0.409508 siguientes especialistas 0.418218 siguientes síndromes 0.413185 rayos x 0.412063 niño ayuda 0.413721 escamas llamadas placas 0.409897 tumores benignos 0.516528 tumor vascular benigno 0.534618 Instituto Nacional 0.412348 alta potencia 0.411312 células llamadas 0.410367 tumores vasculares benignos 0.9178 venas sanas vecinas 0.421159 nuevos tipos 0.412108 sangre circula 0.414383 medicamentos propranolol hydrochloride 0.437459 angiofibroma nasofaríngeo 0.468048 hemangioendotelioma epitelioides 0.436434 once tipos 0.436191 glándula tiroides 0.427118 posibles efectos tardíos 0.424225	adultos jóvenes 0.418525 siguientes tumores 0.604051 granulomas piógenos 0.445724 hemangioma capilar lobulillar 0.505924 siguientes tipos 0.41901 ondas sonoras 0.412577 efectos tardíos 0.50862 PDQ Efectos tardíos 0.43716 vías respiratorias 0.428225 tarde.ampliar ecografía 0.413763 granuloma piógeno 0.509033 IRMN).Ampliar Imágenes 0.410245 sección opciones 0.41178 hemangioendoteliomas epitelioides 0.418326 PDQ Tratamiento 0.421361 afección llamada esclerosis 0.414532 siguientes signos 0.417619 siguientes casos 0.414811 Physician Data Query 0.425443 propranolol iv 0.42341 insuficiencia cardíaca 0.475544 hemangioma epitelioide 0.568564 siguientes pruebas 0.434586 angiofibromas nasofaríngeos juveniles 0.440153	CLICK HERE
16681	National Cancer Institute	Html	en	Cancer Moonshot℠ Blue Ribbon Panel Members	Information about the Cancer Moonshot Blue Ribbon Panel of experts. The panel was established to ensure the Cancer Moonshot's goals and approaches are grounded in the best science.	Walton Endowed Chair 0.567818 Cancer Genome Computational 0.597352 National Cancer Advisory 0.650925 cancer advocacy groups 0.631303 Integrative Cancer Research 0.659981 Cancer Disparities Program 0.610947 C. Zamecnik Chair 0.57469 Senior Vice President 0.528963 Harvard Medical School 0.539573 Chief Executive Officer 0.838453 Moores Cancer Center 0.633784 Cancer Center 0.989395 Principal Deputy Director 0.559096 Kimmel Cancer Center 0.636717 MGH Cancer Center 0.643509 Associate Professor 0.561481 Texas MD Anderson 0.619653 Scott Cancer Center 0.628322 Hopkins University School 0.586476 Lurie Comprehensive Cancer 0.604578 National Brain Tumor 0.535602 Alumni Distinguished Professor 0.55884 cancer health disparities 0.665713 Thomas Jefferson University 0.541957 cancer prevention 0.57231	Lineberger Comprehensive Cancer 0.60209 Huntsman Cancer Institute 0.643082 Ph.D 0.602332 Anderson Cancer Center 0.720144 Dana-Farber Cancer Institute 0.630726 Louisiana State University 0.545794 Pfizer Worldwide Research 0.555824 National Cancer Institute 0.714187 Cancer Research 0.712054 Sidney Kimmel 0.530896 Hospital Cancer Center 0.648303 Blue Ribbon Panel 0.726957 M.D 0.540388 Executive Vice President 0.545293 MD Anderson Cancer 0.692003 Ludwig Cancer Research 0.634757 Clinical Cancer Care 0.584227 Comprehensive Cancer Center 0.832766 Clausen Distinguished Professor 0.578861 Cancer Survivorship 0.543835 Kimmel Comprehensive Cancer 0.643464 Vanderbilt-Ingram Cancer Center 0.63051 University Feinberg School 0.566744 Deputy Director 0.630447	CLICK HERE
16775	National Cancer Institute	Html	es	Cancell/Cantron/Protocel (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso de Cancell/Entelev como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.	Centro Nacional 0.429084 New Hampshire Avenue 0.419912 cabo ensayos 0.419001 Drug Administration 0.412413 NCI Best Case 0.439351 tipo cancell 0.440349 mejores pruebas 0.415762 datos bibliográficos pubmed 0.42161 siguientes preguntas 0.412513 James V 0.418429 National Cancer Institute 0.425345 siguientes riesgos 0.416342 seguro médico 0.411884 Instituto Nacional 0.685274 vitamina e 0.418575 Salud Complementaria 0.444832	Visuals Online 0.415001 complementarias revisa 0.421711 Physician Data Query 0.488672 nombre cancell 0.440323 Estados Unidos 0.994944 libre uso 0.416016 suficiente actividad 0.418205 siguientes sustancias 0.422749 página manejo 0.413947 ¿El tratamiento 0.424367 ¿Los beneficios 0.412704 juntos cam 0.411781 Series Program 0.412549 medicina complementaria 0.882014 Institutos Nacionales 0.47694	CLICK HERE
16841	National Cancer Institute	Html	en	Nanotechnology Characterization Laboratory (NCL)	The Nanotechnology Characterization Laboratory (NCL) is accelerating the development of promising nanotechnology therapies and diagnostics.	extensive educational outreach 0.634447 FDA 0.244496 Nanotechnology Characterization Laboratory 0.767048 oncology-directed therapies 0.46705 great strides 0.507003 pursuit 0.246467 death rate 0.462099 Drug Administration 0.456372 unique setup 0.432854 progression 0.249487 concert 0.241265 effort 0.242009 extraordinary opportunity 0.441323 dozen NCL collaborators 0.920466 disadvantages 0.25207 relatively limited time 0.630205 biocompatibility trends 0.467853 National Cancer Institute 0.664151 National Institute 0.449153 Food 0.241207	human clinical trials 0.632541 development 0.239992 clinical translation 0.459921 therapeutic outcomes 0.469235 diagnosis 0.245742 difficult diseases 0.491415 diagnostic capabilities 0.458058 novel nanomedicines 0.45591 vast array 0.436858 different nanomaterials 0.457741 Standards 0.240975 population 0.239972 diagnostics 0.244317 advantages 0.242363 cancers 0.321573 foremost nanotechnology research 0.719052 preclinical characterization 0.513184 novel treatment strategies 0.62837 incidence 0.254427 multi-disciplinary team 0.450189	CLICK HERE